Indo-MIM
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Subscription
- Qualified institutionalQIB
- 204.34×
- Big non-institutionalbNII · above ₹10 lakh
- 57.68×
- Small non-institutionalsNII · ₹2–10 lakh
- 36.35×
- Retail individualRII · up to ₹2 lakh
- 6.48×
- Employeesreserved quota
- 9.31×
Grey market premium
Unofficial and indicative — not a forecast
Day-wise premium · 7 observations
| Date | GMP | % | Sauda | Est. listing | Gain / lot |
|---|---|---|---|---|---|
| 30 Jul 2026 | ₹184 | — | ₹4,200 | — | ₹5,520 |
| 29 Jul 2026 | ₹187 | — | ₹4,300 | — | ₹5,610 |
| 28 Jul 2026 | ₹190 | — | ₹4,300 | — | ₹5,700 |
| 27 Jul 2026 | ₹190 | — | ₹4,300 | — | ₹5,700 |
| 26 Jul 2026 | ₹190 | — | ₹4,300 | — | ₹5,700 |
| 25 Jul 2026 | ₹181 | — | ₹4,100 | — | ₹5,430 |
| 24 Jul 2026 | ₹184 | — | ₹4,200 | — | ₹5,520 |
Gain per lot assumes the premium holds to listing and that the application is allotted — allotment in an oversubscribed issue is a lottery, so it is indicative, not expected. Sauda is the rate paid for a submitted application itself.
Issue details
- IPO date
- 23 Jul 2026 – 27 Jul 2026
- Listing date
- 30 Jul 2026
- Face value
- ₹1 per share
- Price band
- ₹461 – ₹485
- Issue price
- ₹485 per share
- Lot size
- 30 shares
- Sale type
- Fresh capital cum OFS
- Issue type
- Book Building issue
- Listing at
- NSE
- Total issue size
- ₹3,812 Cr
- Fresh issue
- ₹501 Cr 1,03,27,835 shares
- Offer for sale
- ₹3,311 Cr 6,82,91,022 shares
- Market cap at offer price
- ₹23,981 Cr
- Promoter holding
- 92.94% → 77.65% pre-issue → post-issue
- ISIN
- INE084101034
- CIN
- U28110KA1996PLC137499
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead managers
- HDFC Bank Ltd.
- Registered office
- 45(P), KIADB Industrial Area, Hoskote, Bangalore 562 114, Karnataka, India
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| QIB | 1,56,83,772 | 28.57% | 28.47% |
| Anchor investor · within QIB | 2,35,25,656 | — | 42.70% |
| NII (HNI) | 1,17,62,829 | 21.43% | 21.35% |
| bNII > ₹10L · within NII | 78,41,885 | — | 14.23% |
| sNII < ₹10L · within NII | 39,20,944 | — | 7.12% |
| Retail (RII) | 2,74,46,600 | 50.00% | 49.82% |
| Employee | 2,00,000 | — | 0.36% |
| Market maker | 0 | — | 0.00% |
| Total issue | 5,50,93,201 | — | 100.00% |
Net offer to the public of 5,48,93,201 shares, out of a total issue of 5,50,93,201. Indented rows sit inside the category above them and are not added to it.
Application size
Minimum 30 shares per lot, in multiples, at ₹485
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 30 | ₹14,550 |
| Retail (max) | 13 | 390 | ₹1,89,150 |
| S-HNI (min) | 14 | 420 | ₹2,03,700 |
| S-HNI (max) | 68 | 2,040 | ₹9,89,400 |
| B-HNI (min) | 69 | 2,070 | ₹10,03,950 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
₹485 per share
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 11.02 | 10.79 |
| P/E (×) | 44.01 | 44.95 |
| Price to book (×) | 10.63 | — |
| Market cap | — | ₹23,981 Cr |
Key performance indicators
Latest reported period, consolidated
- Return on net worth
- 19.94%
- ROCE
- 25.00%
- Debt / equity
- 0.57
- PAT margin
- 12.73%
- EBITDA margin
- 28.01%
- NAV per share
- ₹45.63
- Price to book
- 10.63
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
Company financials
Consolidated ·₹ crore unless a row shows % or ×, as reported in the offer document
| Period ended | FY26 | FY25 | FY24 |
|---|---|---|---|
| Profit and loss | |||
| Total income | 4,320.7 | 3,373.97 | 2,900.38 |
| Revenue from operations | 4,192.98 | 3,329.58 | 2,870.4 |
| Other income | 127.72 | 44.4 | 29.99 |
| Total expenses | 3,508.93 | 2,691.89 | 2,388.7 |
| Operating profit | 811.77 | 682.08 | 511.68 |
| Operating margin | 18.79% | 20.22% | 17.64% |
| Profit before tax | 733.74 | 581 | 435.21 |
| Profit after tax | 533.54 | 423.73 | 283.73 |
| PAT margin | 12.35% | 12.56% | 9.78% |
| Balance sheet | |||
| Total assets | 4,897.33 | 4,140.84 | 3,757.51 |
| Current assets | 2,471.92 | 2,127.49 | 1,827.43 |
| Current liabilities | 1,182.41 | 1,238.66 | 893.64 |
| Total liabilities | 2,077.78 | 1,941.41 | 1,707 |
| Net worth | 2,819.55 | 2,199.43 | 2,050.51 |
| Current ratio | 2.09× | 1.72× | 2.04× |
| Return on equity | 18.92% | 19.27% | 13.84% |
| Cash flow | |||
| Operating cash flow | 1,077.24 | 506.27 | 458.33 |
| Investing cash flow | -536.55 | -335.93 | -475.51 |
| Financing cash flow | -356.08 | -237.94 | -92.68 |
| Net cash flow | 214.94 | -58.24 | -98.6 |
Objects of the issue
Stated use of the net proceeds— open a row for the issuer's full explanation
1 Repayment/prepayment of outstanding borrowings ₹400 Cr
The company proposes to utilize Net Proceeds towards repayment/prepayment, in full or part, of certain outstanding borrowings availed from various banks and financial institutions to reduce outstanding indebtedness and maintain favorable debt-equity ratio.
2 General corporate purposes —
The company proposes to deploy the balance Net Proceeds towards general corporate purposes including strategic initiatives, funding growth opportunities, meeting exigencies, and general corporate expenses, subject to not exceeding 25% of Gross Proceeds.
1 of 2 objects carry no stated amount — typically general corporate purposes, funded from whatever remains — so the total above is the quantified portion only, not the whole issue.
Selling shareholders
Existing holders selling into the offer — these proceeds go to the seller, not to the company
| Seller | Capacity | Shares offered | Avg. cost |
|---|---|---|---|
| Green Meadows Investments Ltd | Corporate Promoter Selling Shareholder | 6,05,24,322 | ₹2.67 |
| Anuradha Koduri | Individual Promoter Group Selling Shareholder | 54,59,000 | ₹1.25 |
| Indian Institute of Technology Madras | Other Selling Shareholder | 23,07,700 | ₹0 |
3 sellers offering 6,82,91,022 shares.
About Indo-MIM
INDO-MIM Limited, incorporated in 1996 and converted to public company in 2024, is a precision manufacturing company specializing in metal injection molding (MIM) and related technologies. The company operates 15 manufacturing facilities across India, United States, United Kingdom, and Mexico, serving global customers primarily in North America (43.68% of FY2026 revenue) and Europe (19.97%). With exports representing 77.20% of FY2026 revenue, the company generates revenue from complex precision components used in automotive (24.61%), defence (18.69%), medical (18.08%), aerospace (11.96%), and consumer products (10.80%) segments. The company has demonstrated strong growth, with revenue increasing from ₹28,703.95 million in FY2024 to ₹41,929.85 million in FY2026 (CAGR 20.86%).
Management
Krishna Chivukula
MD
Krishna Chivukula Jr.
CEO
Jagadamba Chandrasekhar
Director
Raj Chivukula
Director
Strengths
As stated in the offer document
Global leadership in manufacturing precision engineering components using MIM technology
The company is the largest manufacturer globally of precision engineering components using MIM technology with a market share of 6.8% in terms of revenue from MIM in Calendar Year 2025 and has held this position for the last six years.
Long-standing relationships with Indian and global OEM customers
The company has diverse customer base with long-standing relationships with several Indian and global OEMs. For Fiscals 2026, 2025 and 2024, repeat customers contributed 91.60%, 90.91% and 93.76% respectively of revenue from operations.
Diversified product portfolio catering to applications across multiple industries
The company has diverse product portfolio serving customers across automotive, defence, medical devices, consumer durables, and aerospace components. The company manufactured over 9,000 types of products in Fiscal 2026.
Backward integrated, dual-shore manufacturing capabilities with focus on efficiency
The company operates 15 manufacturing facilities across India, United States, United Kingdom and Mexico. As of March 31, 2026, the company has the world's largest installed capacity for MIM products and deployed 436 robots and 476 IoTs enabled machines.
Export driven player with extensive global distribution capability
The company has global sales capabilities with three sales offices in China, Germany and United States and 13 sales representatives across multiple countries. Revenue from outside India was 77.20%, 89.92% and 88.26% for Fiscals 2026, 2025 and 2024 respectively.
Experienced promoters and management team supported by large employee base
The company is led by Promoters with significant experience - Krishna Chivukula has over 30 years of experience in MIM industry. As of March 31, 2026, the company had 4,424 permanent employees in India, out of which 4,100 are engineers, metallurgists, designers, toolmakers and technicians.
Track record of robust financial performance
The company demonstrated consistent revenue growth with revenue from operations of ₹ 41,929.85 million, ₹ 33,295.77 million and ₹ 28,703.95 million for Fiscals 2026, 2025 and 2024 respectively, representing growth rates of 25.93%, 16.00% and 6.60%.
Risk factors
As stated in the offer document
Customer Concentration Risk
The company derives a significant portion of revenue from its top 10 customers, who contributed 38.41%, 38.94% and 42.00% of revenue from operations in Fiscals 2026, 2025 and 2024, respectively. Loss of such customers or significant reduction in demand could adversely affect business operations and financial performance.
Export Dependency and Geographic Concentration
The company's business is heavily dependent on exports, with revenue from outside India representing 77.20%, 89.92% and 88.26% of total revenue in Fiscals 2026, 2025 and 2024, respectively. Economic slowdowns in export markets or trade restrictions could significantly impact operations.
Lack of Long-term Customer Commitments
The company operates on a purchase order basis without definitive agreements or long-term commitments from customers. This creates uncertainty in demand visibility and exposes the company to order cancellations, changes, or delays without compensation.
Raw Material Supply Chain Dependencies
The company's operations depend on uninterrupted availability of key raw materials from domestic and international suppliers. Any disruption affecting supply or market prices could adversely affect production schedules, cost structure and financial performance.
Import Dependency for Raw Materials
The company imports 60.95%, 61.80% and 59.63% of raw materials in Fiscals 2026, 2025 and 2024, respectively. Import restrictions, global commodity price fluctuations, or geopolitical tensions could adversely affect business operations and costs.
Manufacturing Facility Operational Risks
The company operates 15 manufacturing facilities globally, and any unscheduled disruption due to power failure, mechanical breakdown, natural disasters, or other events could reduce ability to meet customer conditions and adversely affect sales and revenue.
Geographic Concentration in South India
The company's manufacturing facilities in India are concentrated in south India (Karnataka, Tamil Nadu and Andhra Pradesh). Adverse developments affecting this region could require significant capital expenditure or suspension of operations.
Regulatory Compliance and Cost Audit Issues
The company's Promoters, Directors and KMPs have received show cause notices for alleged non-compliance with mandatory cost auditor appointment requirements, which could impact reputation and subject the company to regulatory actions.
Company Analysis
from PROSPECTUSINDO-MIM Limited manufactures precision metal injection molded components and operates across automotive, aerospace, defence, medical, and consumer products sectors globally.
INDO-MIM Limited, incorporated in 1996 and converted to public company in 2024, is a precision manufacturing company specializing in metal injection molding (MIM) and related technologies. The company operates 15 manufacturing facilities across India, United States, United Kingdom, and Mexico, serving global customers primarily in North America (43.68% of FY2026 revenue) and Europe (19.97%). With exports representing 77.20% of FY2026 revenue, the company generates revenue from complex precision components used in automotive (24.61%), defence (18.69%), medical (18.08%), aerospace (11.96%), and consumer products (10.80%) segments. The company has demonstrated strong growth, with revenue increasing from ₹28,703.95 million in FY2024 to ₹41,929.85 million in FY2026 (CAGR 20.86%).
Objects of the Issue
- Repayment or pre-payment of certain loan facilities p.27
- General corporate purposes and other objects as described in Objects of the Offer section p.3
- General corporate purposes ₹5,000.00 million p.86
- Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by our Company ₹4,000.00 million p.106
- General corporate purposes [●] p.132
- To be determined by the Board and disclosed in prospectus
Issue Structure
- Total Issue
- Up to [●] Equity Shares aggregating up to ₹[●] million
- Fresh Issue
- Up to [●] Equity Shares of face value of ₹1 each aggregating up to ₹5,000.00 million
- Offer for Sale
- Up to 68,291,022 Equity Shares of face value of ₹1 each aggregating up to ₹[●] million
- Face Value
- ₹1 each
Business Model
INDO-MIM manufactures and supplies high-precision metal injection molded components to OEMs and customers globally on a purchase order basis. The company generates revenue from sale of precision components across multiple end-use industries. Cost of materials consumed represents 20.87% of FY2026 revenue. The company operates capital-intensive manufacturing facilities equipped with advanced robotics (436 robots deployed as of March 31, 2026) and IoT-enabled machines (476 deployed), enabling optimization of production efficiency and cost management.
Business Segments
SWOT Analysis
- • Global MIM market leadership with 6.8% revenue share(p.136)
- • Diversified global customer base with long-standing OEM relationships(p.136)
- • Diversified product portfolio across multiple end-markets(p.136)
- • Dual-shore manufacturing with cost and logistical advantages(p.136)
- • Export-driven with presence in 55 countries(p.136)
- • Experienced management with 30+ years industry expertise(p.136)
- • Consistent revenue growth trajectory(p.137)
- • Global market leader in MIM with 6.8% market share held for six consecutive years(p.196)
- • World's largest installed capacity for MIM products as of March 31, 2026(p.181)
- • Fastest new product introduction in MIM industry at 45-50 new tools per month(p.199)
- • Diversified technology portfolio covering MIM, ceramic injection molding, investment casting, precision machining, and 3D printing(p.196)
- • Strong financial performance with 25.5% EBITDA margin and 12.7% PAT margin in FY2026(p.199)
- • Extensive global manufacturing footprint with 15 facilities across India, US, UK, and Mexico(p.197)
- • Long-standing customer relationships with 738 customers across multiple industries(p.200)
- • Strong revenue growth trajectory with 25.93% growth in FY2026(p.202)
- • Global manufacturing footprint across multiple countries with diversified operations(p.220)
- • Strong export capability with 77% of revenue from markets outside India(p.216)
- • Diversified geographic revenue base reducing dependence on single market(p.216)
- • Multiple quality certifications demonstrating operational excellence(p.217)
- • Established R&D capability in emerging manufacturing technologies(p.217)
- • Backward integration strategy with in-house powder manufacturing(p.215)
- • Global revenue diversification across 55 countries reduces dependence on single market(p.359)
- • Strong export revenue base; 77.2% of FY2026 revenues from exports(p.359)
- • Diversified product portfolio across multiple end-use industries (automotive, defense, medical, aerospace, consumer)(p.360)
- • Strong profitability metrics with PAT margin of 12.72% in FY2026(p.361)
- • Improving return on capital employed (26.60% in FY2026 vs 19.59% in FY2024)(p.362)
- • Strong cash generation from operations; ₹10,772.41 million in FY2026(p.378)
- • Revenue growth of 25.93% in FY2026; operating profit increased 19.01%(p.374)
- • Revenue concentration from top 10 customers(p.22)
- • High export dependency creates geographic risk(p.23)
- • Lack of long-term customer commitments(p.24)
- • Raw material supply concentration risk(p.25)
- • Geographic concentration of manufacturing in South India(p.27)
- • Promoter has history of regulatory disqualification(p.28)
- • Pending regulatory show cause notices regarding cost auditor compliance(p.28)
- • Debt covenant restrictions limiting operational flexibility(p.39)
- • High counterparty credit risk and customer payment delays impact cash flows and receivables(p.40)
- • Substantial capital expenditure and working capital requirements necessitate additional financing(p.40)
- • Inadequate stamping and registration of certain lease agreements poses legal and financial risks(p.42)
- • Insurance coverage may not adequately protect against all unforeseen losses and claims(p.41)
- • Contingent liabilities from tax disputes and excise/GST demands pose material risk(p.42)
- • Outstanding legal proceedings against Company and related parties may divert management resources(p.44)
- • Lease agreement terminations or expirations could disrupt operations and impose relocation costs(p.47)
- • Labor intensive operations subject to unionization and wage settlement obligations(p.47)
- • Missing historical corporate records create challenges in establishing validity of past transactions(p.50)
- • Majority of Directors lack experience in listed company governance and regulatory compliance(p.51)
- • Heavy dependence on promoter group ownership (92.94% pre-Offer)(p.93)
- • Missing historical corporate records on share allotments and transfers(p.89)
- • Significant financial indebtedness of ₹12,123.49 million on consolidated basis(p.106)
- • Debt-to-equity ratio of 0.39 indicating moderate leverage(p.140)
- • EBITDA margin declining from 28.01% to 25.54% year-over-year(p.140)
- • High dependence on top five customers representing 28.95% of FY2026 revenue(p.200)
- • Single largest customer concentration at 7.97% of FY2026 revenue, though improved from 13.69% in FY2024(p.200)
- • Declining capacity utilization in MIM technology from 35.76% in FY2025 to 30.58% in FY2026(p.211)
- • Debt to total net worth ratio of 0.39 as of March 31, 2026, indicating leveraged capital structure(p.199)
- • Geographically concentrated revenue with North America at 43.68% and India at 22.80% in FY2026(p.202)
- • High customer concentration with top 5 customers representing 28.95% of revenue(p.216)
- • Lack of long-term customer commitments with orders placed on as-needed basis(p.217)
- • Customer supply agreements lack purchase volume commitments and can be terminated without cause(p.217)
- • Significant reliance on imported raw materials with 60.95% of purchases from outside India(p.215)
- • Dependence on key suppliers with risk of supply interruption(p.215)
- • Substantial employee unionization with 1,068 of 4,424 employees as union members(p.219)
- • Significant dependence on top 10 customers; 38.41% of FY2026 revenues(p.383)
- • Dependence on limited number of raw material suppliers(p.383)
- • Significant impairments in goodwill and fixed assets; ₹807.60 million in FY2026 exceptional charges(p.376)
- • Total debt of ₹10,904.88 million as of March 31, 2026(p.361)
- • Material unhedged foreign currency exposure of ₹214.16 million in FY2026(p.359)
- • Multiple pending GST/tax disputes with material exposure exceeding ₹600 million(p.392)
- • Regulatory notice from Central Drugs Standard Control Organization regarding unlicensed manufacture of medical devices(p.387)
- • Strategic investment in new manufacturing facilities and technology development for growth(p.40)
- • Ability to expand product portfolio to meet evolving customer preferences and market trends(p.49)
- • Investment in research and development to maintain competitive position and address market changes(p.49)
- • Opportunity to establish new manufacturing facility for iron powder production by end of Fiscal 2027(p.47)
- • Industrial Gas Turbine market expansion supporting growth(p.114)
- • Capacity expansion in advanced vacuum casting capabilities(p.107)
- • Geographic expansion via UK operations with European market access(p.115)
- • Debt reduction opportunity to improve financial metrics(p.106)
- • Strategic repositioning of acquisition towards OEM-focused manufacturing(p.114)
- • Global MIM market growing at 9.2% CAGR from USD 4.0 billion (2025) to USD 6.2 billion (2030)(p.175)
- • Medical devices segment expected to grow at 11.6% CAGR through 2030(p.176)
- • Aerospace segment MIM demand growing at 9.2% CAGR as manufacturers pursue lightweighting(p.176)
- • India's manufacturing GVA share projected to rise from 12.9% (FY2026) to 14.8% (FY2032) driven by PLI schemes(p.160)
- • 3D printing market expanding at 22.3% CAGR from USD 23 billion (2025) to USD 63 billion (2030)(p.187)
- • India emerging as manufacturing hub with China+1 strategies directing investment to India(p.158)
- • Strategy to expand new customer acquisition with 308 new customers added in FY2026(p.203)
- • Backward integration strategy with iron powder manufacturing facility coming online by end of FY2027(p.203)
- • Expansion of global presence through organic and inorganic growth(p.201)
- • Backward integration expansion with iron powder production facility in development(p.215)
- • Recent acquisitions of manufacturing capabilities in new markets (UK, USA, Mexico)(p.234)
- • Potential for growing domestic Indian market with revenue increasing from 10.08% in FY2025 to 22.80% in FY2026(p.216)
- • Joint venture opportunity with AUFLEX Co. Ltd for specialized foldable hinge production(p.235)
- • Aerospace segment showing strong growth potential with increasing demand for high-tolerance components(p.360)
- • Dual-shore manufacturing strategy to diversify geographic risk and access new markets(p.359)
- • Expand into higher-complexity, lower-volume components with better margins(p.360)
- • Medical device sector expansion; multiple manufacturing licenses recently obtained for Class A, B, C devices(p.397)
- • Growth in defense segment driven by stable procurement cycles and stringent quality requirements(p.360)
- • International expansion to offset domestic regulatory and competitive pressures(p.359)
- • Export market cyclicality and slowdown risks(p.23)
- • US tariff policy impact on export competitiveness(p.24)
- • Raw material supply chain disruptions(p.25)
- • Global manufacturing industry cyclicality(p.32)
- • International business operational risks and regulatory uncertainty(p.29)
- • Intense price competition from global competitors(p.37)
- • Transportation and logistics disruption risks(p.38)
- • Foreign exchange rate volatility and unhedged exposure impact margins and cash flows(p.40)
- • Industry faces cost structure pressures from high tooling costs and feedstock price volatility(p.43)
- • Concentrated supply of MIM-grade powders creates supply chain rigidity and dependency(p.43)
- • Multi-stage processing creates defect probability and yield risks requiring tight process control(p.43)
- • MIM technology economically constrained to small, high-volume components limiting addressable market(p.43)
- • Competition from precision CNC machining, metal additive manufacturing, and die casting erodes competitive advantage(p.43)
- • Lengthy OEM qualification timelines and conservative procurement practices delay commercialization(p.43)
- • Rising ESG and regulatory pressures increase compliance costs and require cleaner production systems(p.43)
- • Environmental law violations may result in fines, operational shutdowns, and permit revocation(p.44)
- • Regulatory permit renewals may be delayed or denied, disrupting business operations(p.47)
- • Natural disasters, epidemics, pandemics, and civil unrest beyond company control may disrupt operations(p.56)
- • Global economic slowdown and Indian economic uncertainty could reduce product demand(p.57)
- • High inflation may increase costs without proportional price increases, reducing margins(p.59)
- • Competition law enforcement and adverse interpretation could restrict growth and impose penalties(p.57)
- • Indian tax regime changes including GST, GAAR, and new tax laws create uncertainty and compliance costs(p.58)
- • Funding requirements not appraised by independent institutions(p.106)
- • Discretionary management flexibility in fund deployment(p.132)
- • No global listed competitors for benchmark comparison(p.137)
- • Interest rate and external cost fluctuation exposure(p.106)
- • Dependent on continued lender consent for strategic initiatives(p.132)
- • Supply chain disruptions from US-Iran conflict causing Strait of Hormuz blockage affecting trade routes and energy costs(p.161)
- • Global growth moderation from 3.4% (CY2025) to 3.1% (CY2026) due to geopolitical tensions(p.168)
- • Elevated global inflation at 4.4% in CY2026 driven by energy disruptions compressing industrial margins(p.156)
- • High tooling and raw material costs limiting economic viability for low-volume components(p.179)
- • Competition from alternative technologies including CNC machining, metal additive manufacturing, and die casting(p.179)
- • Concentrated supply of MIM-grade powders creating supply chain rigidity(p.179)
- • China's MIM market growth at 8.3% CAGR (lower than global 9.2%) while remaining 22% of global market(p.178)
- • ESG and regulatory pressures from high carbon intensity of sintering and binder removal emissions(p.179)
- • Highly competitive precision components industry with multiple global competitors(p.219)
- • Significant reliance on imports creates vulnerability to trade restrictions and commodity price fluctuations(p.215)
- • Exposure to environmental regulations across multiple jurisdictions(p.218)
- • Manufacturing facilities subject to hazardous activity risks(p.218)
- • Dependence on power and fuel supply continuity for manufacturing operations(p.215)
- • Complex regulatory requirements for defense manufacturing with licensing constraints(p.221)
- • Foreign exchange risk; rupee depreciation increases input costs and affects revenue realization(p.359)
- • Exposure to multiple jurisdictions' regulatory frameworks and geopolitical developments(p.359)
- • Intense competition from global and domestic peers in precision components industry(p.382)
- • Automotive sector subject to evolving emission norms and electrification trends(p.360)
- • Cyclicality and volatility in end-use industry demand and product mix shifts(p.360)
- • Commodity price volatility affecting raw material costs despite pass-through arrangements(p.382)
- • Contingent tax liabilities of ₹2,274.49 million from GST and income tax disputes(p.379)
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Green Meadows Investments Ltd | Corporate Promoter | — | — |
| Krishna Chivukula | Promoter | — | — |
| Krishna Chivukula Jr. | Promoter | — | — |
| Raj Chivukula | Promoter | — | — |
| Jagadamba Chandrasekhar | Promoter | — | — |
| Anuradha Koduri | Promoter Group | — | — |
| Green Meadows Investments Ltd | Corporate Promoter | 90.44% | — |
| Anuradha Koduri | Promoter | 1.13% | — |
| Indian Institute of Technology Madras | Promoter | 0.95% | — |
| Green Meadows Investments Ltd | Corporate Promoter | 90.44% | — |
| Krishna Chivukula | Promoter | 0.21% | — |
| Jagadamba Chandrasekhar | Promoter | 1.16% | — |
| Anuradha Koduri | Member of the Promoter Group | 1.13% | — |
| Krishna Chivukula | Promoter | — | — |
| Krishna Chivukula Jr. | Promoter | — | — |
| Green Meadows Investments Ltd | Corporate Promoter | — | — |
| Krishna Chivukula | Promoter | 0.21% | — |
| Jagadamba Chandrasekhar | Promoter | 1.16% | — |
| Krishna Chivukula Jr. | Promoter | — | — |
| Raj Chivukula | Promoter | — | — |
| Green Meadows Investments Ltd | Corporate Promoter | 90.44% | — |
| Krishna Chivukula | Promoter | 0.21% | — |
| Krishna Chivukula Jr. | Promoter | Nil | — |
| Raj Chivukula | Promoter | Nil | — |
| Jagadamba Chandrasekhar | Promoter | 1.16% | — |
| Green Meadows Investments Ltd | Parent Company | — | — |
| Krishna Chivukula | Promoter/Chairman & Managing Director | — | — |
| Jagadamba Chandrasekhar | Promoter/Non-executive director | — | — |
| Green Meadows Investments Ltd | Promoter Group | 90.44% | — |
| Anuradha Koduri | Promoter | 1.13% | — |
| Indian Institute of Technology Madras | Promoter | 0.95% | — |
| Green Meadows Investments Ltd | Corporate Promoter Selling Shareholder | — | — |
| Indian Institute of Technology Madras | Other Selling Shareholder | — | — |
| Anuradha Koduri | Promoter Group Selling Shareholder | — | — |
Leadership
Auto-extracted from the company's PROSPECTUS using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official PROSPECTUS before relying on it.